FDA Inspection
ImpactLifeImpactLife – FDA Inspection, Sep 18, 2019
Record Details
This FDA Inspection record concerns ImpactLife, with an inspection on September 18, 2019, issued by the Center for Biologics Evaluation and Research, covering biologics.
View Company Profile
ID · 0bbed59b-4ca9-48a4-bfb0-97f5e537af7a
Inspection Facts
No Action Indicated (NAI)
No objectionable conditions or practices were found during the inspection.
- Inspection number
- 1108056
- FDA center
- Biologics
- Project area
- Blood and Blood Products
Other FDA inspections of ImpactLife
5| Date | Classification | Office | Project area |
|---|---|---|---|
| November 19, 2025 | Not classified | Chicago District Office | |
| August 30, 2017 | NAI | Center for Biologics Evaluation and Research | Blood and Blood Products |
| January 22, 2015 | NAI | Center for Biologics Evaluation and Research | Blood and Blood Products |
| March 26, 2013 | NAI | Center for Biologics Evaluation and Research | Blood and Blood Products |
| April 6, 2011 | NAI | Center for Biologics Evaluation and Research | Blood and Blood Products |
Other documents for ImpactLife
- FDA Inspection 1293564 - 2025-11-19
- FDA Inspection 1025427 - 2017-08-30
- FDA Inspection 910949 - 2015-01-22
- FDA Inspection 824712 - 2013-03-26
- FDA Inspection 718476 - 2011-04-06
Document or profile
One record shows the event. A profile shows the pattern.
Buy this document for the source file and details behind this single event.
Choose full profile access to connect related records, sites, people, citations, and enforcement history in one view.